123 related articles for article (PubMed ID: 322257)
1. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
Bendtzen K
Scand J Immunol; 1977; 6(1-2):125-31. PubMed ID: 322257
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
Bendtzen K
Scand J Immunol; 1977; 6(1-2):126-31. PubMed ID: 322258
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte migration inhibitory factor (LIF). II. Partial biochemical characterization of the substrate specificities for this lymphokine.
Bendtzen K
Scand J Immunol; 1977; 6(1-2):133-40. PubMed ID: 322260
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte migration inhibitory factor (LIF). IV. 3',5'-cGMP protects LIF against inactivation by the esterase inhibitor phenylmethylsulfonyl fluoride.
Bendtzen K
Scand J Immunol; 1977; 6(12):1357-61. PubMed ID: 203999
[TBL] [Abstract][Full Text] [Related]
5. Some physicochemical properties of human leucocyte migration inhibitory factor (LIF).
Bendtzen K
Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):471-6. PubMed ID: 11637
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amides.
Bendtzen K
Scand J Immunol; 1977; 6(10):1055-62. PubMed ID: 335493
[TBL] [Abstract][Full Text] [Related]
7. Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIF.
Bendtzen K
J Clin Lab Immunol; 1979 Apr; 2(1):37-43. PubMed ID: 95804
[TBL] [Abstract][Full Text] [Related]
8. Evidence that human leukocyte inhibitory factor (LIF) is an esterase.
Rocklin RE; Rosenthal AS
J Immunol; 1977 Jul; 119(1):249-52. PubMed ID: 326958
[No Abstract] [Full Text] [Related]
9. Differential effect of the serine protease inhibitor phenyl methyl sulfonyl fluoride on cytochemically detectable esterases in human leucocytes and platelets.
Dufer J; Trentesaux C; Desplaces A
Scand J Haematol; 1984 Jan; 32(1):25-32. PubMed ID: 6364322
[TBL] [Abstract][Full Text] [Related]
10. Human leucocyte response to migration inhibitory activity from lymphocytes. Modification by aprotinin, Tranexamic acid and phenylmethyl sulfonylfluoride.
Coeugniet E; Søeberg B; Bendixen G
Acta Med Scand; 1978; 203(3):191-5. PubMed ID: 305717
[TBL] [Abstract][Full Text] [Related]
11. Antibody-dependent cell-mediated cytotoxicity in humans. III. Effect of protease inhibitors and substrates.
Trinchieri G; De Marchi M
J Immunol; 1976 Apr; 116(4):885-91. PubMed ID: 1254969
[TBL] [Abstract][Full Text] [Related]
12. The enhancement of MIF activity by inhibition of macrophage associated esterases.
Remold HG
J Immunol; 1974 Apr; 112(4):1571-7. PubMed ID: 4592606
[No Abstract] [Full Text] [Related]
13. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
Goetzl EJ; Rocklin RE
J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
[TBL] [Abstract][Full Text] [Related]
14. Production of a serine-protease with macrophage migration-inhibitory factor activity by virus-transformed cells and human tumor cell lines.
Poste G
Cancer Res; 1975 Sep; 35(9):2558-66. PubMed ID: 167963
[TBL] [Abstract][Full Text] [Related]
15. Substrate specificity of the human lymphokine leucocyte migration-inhibitory factor (LIF): radioenzymic assay and inhibition by cGMP.
Bendtzen K
Scand J Immunol; 1979; 10(1):61-7. PubMed ID: 224450
[TBL] [Abstract][Full Text] [Related]
16. Human leucocyte migration inhibitory factor (LIF). V. Specific regulation of the lymphokine serine protease activity by 3',5'-cGMP and, possibly, 2',3'-cCMP.
Bendtzen K
Scand J Immunol; 1978; 8(1):53-61. PubMed ID: 212822
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and functional properties of serine esterases in acidic cytoplasmic granules of cytotoxic T lymphocytes.
Henkart PA; Berrebi GA; Takayama H; Munger WE; Sitkovsky MV
J Immunol; 1987 Oct; 139(7):2398-405. PubMed ID: 3498759
[TBL] [Abstract][Full Text] [Related]
18. The effects of phenylmethanesulfonyl fluoride on delayed organophosphorus neuropathy.
Baker T; Lowndes HE; Johnson MK; Sandborg IC
Arch Toxicol; 1980 Dec; 46(3-4):305-11. PubMed ID: 6263222
[TBL] [Abstract][Full Text] [Related]
19. Kinetic interactions of a neuropathy potentiator (phenylmethylsulfonyl fluoride) with the neuropathy target esterase and other membrane bound esterases.
Mangas I; Vilanova E; Estévez J
Arch Toxicol; 2014 Feb; 88(2):355-66. PubMed ID: 24071788
[TBL] [Abstract][Full Text] [Related]
20. On the inhibitory action of DFP and PMSF on histamine release from isolated rat mast cells [proceedings].
Diamant B; Patkar SA
Agents Actions; 1977 Mar; 7(1):110-1. PubMed ID: 67779
[No Abstract] [Full Text] [Related]
[Next] [New Search]
